Antimicrobial resistance and its impact on cancer care

Antimicrobial resistance (AMR) or drug resistance, including antibiotic resistance, is a growing public health issue and needs urgent attention in countries around the world. Due to a variety of factors, people with cancer are particularly vulnerable to AMR, which is threatening the progress being made in cancer care.

Tackling Antimicrobial Resistance and Antimicrobial Use: A Pan-Canadian Framework for Action

Antimicrobial Resistance Fighter Coalition on LinkedIn: Steps in preventing infections during cancer care

Baxter Italia su LinkedIn: #thinkclinicalnutrition

2023年世界癌症日：整合卫生资源，医疗人人共享-肿瘤瞭望

Impacts of Antimicrobial Resistance on Cancer Care - VIPTA

Antimicrobial resistance resources

PDF) Antibacterial effects of biologically active ingredients in hop provide promising options to fight infections by pathogens including multi-drug resistant bacteria

Baxter Italia su LinkedIn: #renali #dialisi #trapianto #worldkidneyday #saveandsustainlives

Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: A review - ScienceDirect

The impact of antibiotic resistance on cancer treatment, especially in low-and middle-income countries, and the way forward – 2022 – ReAct

Baxter Italia posted on LinkedIn

A view on drug resistance in cancer

The Impact of Antimicrobial Resistance on Cancer Patients